You should not receive mannitol if you have severe kidney disease, lung swelling or congestion, severe heart failure, severe dehydration, bleeding in your brain not caused by surgery, or if your kidneys have already shut down and you are unable to urinate.
There was a mild decrease in blood pressure and a mild increase in cerebral blood flow following mannitol, but little difference between the first hour following a bolus (when the viscosity and hematocrit were decreased) and hours 2-4 (when they were near baseline).
Mannitol is a diuretic that is used to reduce swelling and pressure inside the eye or around the brain. Mannitol is also used to help your body produce more urine.
Adverse reactions more commonly reported during or after the infusion of mannitol (mannitol (mannitol injection) injection) include: Pulmonary congestion, fluid and electrolyte imbalance, acidosis, electrolyte loss, dryness of mouth, thirst, marked diuresis, urinary retention, edema, headache, blurred vision,
Mannitol is a diuretic used to force urine production in people with acute (sudden) kidney failure. Mannitol injection is also used to reduce swelling and pressure inside the eye or around the brain.
Additionally, ingestion of larger amounts of mannitol has a laxative effect, as it binds water in the small intestine, and thus acts osmotically.
Mannitol is a sugar alcohol solution which is sometimes effective in reducing brain swelling after head injury.
At large doses mannitol increases excretion of sodium and potassium. Initially, mannitol acutely raises plasma and extracellular osmolality, which leads to an increase in circulating blood volume.
Medically, it
is given by injection. Effects typically begin within 15 minutes and last up to 8 hours. Common side effects from medical use include electrolyte problems and dehydration.
Mannitol.
| Clinical data |
|---|
| Elimination half-life | 100 minutes |
| Excretion | Kidney: 90% |
| Identifiers |
| show IUPAC name |
Mannitol may cause excessive expansion of the intravascular space when administered in high concentrations at a rapid rate. This may result in congestive heart failure and pulmonary edema.
In patients receiving neurocritical care for cerebral edema, the adjunct of a potassium sparing diuretic (canrenone) to mannitol therapy reduces potassium urinary loss, prevents hypokalemia, and reduces the incidence of new cardiac arrhythmias.
Serum osmolarity must be kept under 320 mOsm/L for mannitol to be effective. In addition, higher osmolarity increases the risk of acute tubular necrosis and renal failure. Use of mannitol may also lead to rebound intracranial hypertension.
Mannitol is contraindicated in patients with TBI and renal failure because of the risk of pulmonary edema and heart failure. HSSs have been suggested as alternative to mannitol.
Unlike other diuretics, the osmotic action of mannitol produces an initial expansion of plasma and extracellular fluid volume, and it has little value as a diuretic. Mannitol does not readily cross the blood–brain barrier and has a role in the management of acute brain injury.
Mannitol is a naturally occurring substance that causes the body to lose water (diuresis) through osmosis. Mannitol promotes diuresis in kidneys by increasing the concentration of filtrates in the kidney and blocking reabsorption of water by kidney tubules.
To this end, the following formula was derived in the study: Total dosage of mannitol (mL of 20% mannitol) = (x + 31.17900 x y - 3.39853 x z - 244.47590)/0.00752, where x = the pretreated ICP (mmH(2)O), y = the haemorrhage location (supratentorial ICH: y = 0, infratentorial ICH: y = 1) and z = the volume of haematoma (
Mannitol is an over-the-counter sweetener that is illegal when knowingly sold in the commission of the drug business, prosecutors said. Jay Mulholland, an FBI special agent who coordinated the investigation, said mannitol is the primary cutting agent for street-level heroin.
Osmotic diuretics are substances that are freely filtered at the glomerulus but are poorly reabsorbed. Mannitol is the prototype of these diuretics. The mechanism by which mannitol produces diuresis is that it increases the osmotic pressure within the lumen of the proximal tubule and the loop of Henle.
Mannitol is considered contraindicated in patients with well established anuria due to acute renal failure. A test dose should be administered in patients with severe renal impairment. Urine output should be monitored during mannitol infusion.
What is Mannitol IV and how is it used? Mannitol IV is a prescription medicine used to treat the symptoms of Elevated Intracranial or Intraocular Pressure. Mannitol IV may be used alone or with other medications. Mannitol IV belongs to a class of drugs called Diuretics, Osmotic Agents.
Mannitol(Osmitrol) generic is an osmotic diuretic, prescribed for increased intracranial pressure, eye pressure, to maintain urine flow in kidney failure patients, and promotion of urinary excretion of toxic materials.
Mannitol is thought to decrease brain volume by decreasing overall water content, to reduce blood volume by vasoconstriction, to reduce CSF volume by decreasing water content. Mannitol may also improve cerebral perfusion by decreasing viscosity or altering red blood cell rheology.
OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; The reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass;
Intravenous injection of 25 grams of mannitol during a large water diuresis may increase sodium and chloride excretion with no change, or even a decline, in urine flow. Intravenous injection of 25 grams of mannitol during hydropenia increases urine flow and salt excretion and decreases urine salt concentration.
